Phase I trial of alpelisib in combination with concurrent cisplatin-based chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck von Day, D., Prawira, A., Spreafico, A., Waldron, J., Karithanam, R., Giuliani, M., Weinreb, I., Kim, J., Cho, J., Hope, A., Bayley, A., Ringash, J., Bratman, S.V., Jang, R., O'Sullivan, B., Siu, L.L., Hansen, A.R.

Volltext